Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

<p>Abstract</p> <p>Background</p> <p>Despite all benefit provided by established therapies prognosis of gastric cancer remains poor. Targeted inhibition of platelet derived growth factor receptor (PDGFR) by imatinib may influence tumor growth and amplify chemotherapeuti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mayr Martina, Becker Karen, Schulte Nadine, Belle Sebastian, Hofheinz Ralf, Krause Annekatrin, Schmid Roland M, Röcken Christoph, Ebert Matthias P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2012-12-01
Seri Bilgileri:BMC Cancer
Konular:
Imatinib
PDGF
Gastric cancer
Chemotherapy
Online Erişim:http://www.biomedcentral.com/1471-2407/12/587
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller